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Abstract. The impact of positron range on PET image reconstruction has often been
investigated as a blurring effect that can be partly corrected by adding an element to
the PET system matrix in the reconstruction, usually based on a Gaussian kernel
constructed from the attenuation values. However, the physics involved in PET is
more complex. In regions where density does not vary, positron range indeed involves
mainly blurring. However, in more heterogeneous media it can cause other effects. This
work focuses on positron range in the lungs and its impact on quantification, especially
in the case of pathologies such as cancer or pulmonary fibrosis, for which the lungs have
localised varying density. Using Monte Carlo simulations, we evaluate the effects of
positron range for multiple radionuclides (18F, 15O, 68Ga, 89Zr, 82Rb, 64Cu and 124I) as,
for novel radiotracers, the choice of the labelling radionuclide is important. The results
demonstrate quantification biases in highly heterogeneous media, where the measured
uptake of high-density regions can be increased by the neighbouring radioactivity from
regions of lower density, with the effect more noticeable for radionuclides with high-
energy positron emission. When the low-density regions are considered to have less
radioactive uptake (e.g. due to the presence of air), the effect is less severe.
1. Introduction
Positron Emission Tomography (PET) is a nuclear imaging technique that allows
imaging of metabolic processes of tissues or organs, providing “functional” information
that can be quantified. Resolution in PET is poorer than in many other imaging
modalities, such as Computerised Tomography (CT) or Magnetic Resonance Imaging
(MRI). Some of the resolution degrading factors in PET are linked to the scanner
specifications while others are directly linked to the physical interactions involved. In
PET, a radiotracer – a biological molecule labelled with a positron-emitting radionuclide
– is given to the patient. Through collisions with several bound electrons of the medium,
the kinetic energy of one emitted positron decreases and, eventually, it annihilates with
an electron; this interaction results usually in the creation of 2 γ photons of 511 keV that
travel almost back-to-back to opposite detectors of the PET scanner (Evans 1955). The
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PET images are then produced via coincidence detection of these two photons. Hence, in
normal practice the reconstructed PET image does not directly describe the distribution
of radioactivity, but the distribution of the annihilation events. The distance between
the location of the emission of the positron and its annihilation with an electron is
known as “positron range” (Lehnert et al. 2011, Derenzo 1979). Since the probability
of annihilation increases as the kinetic energy of the positron decreases due to collisions
with electrons, the positron range depends on the initial kinetic energy of the positron
at emission and the density and composition of the media crossed by the positron before
it annihilates. Its effect on the overall resolution is small for 18F, the clinically most
commonly used radionuclide. However, the resolution degradation linked to positron
range is greater for radionuclides emitting higher energy positrons and in tissues of low
density, such as the lung. Estimated values will be given for some common radionuclides
in Table 2.
Whereas the density of healthy lungs is relatively uniform (aside from airways and
blood vessels), some pathologies can affect the local structure and density of the lung,
for example in the case of lung cancer or interstitial lung diseases. In these cases, the
effect of positron range is spatially variant, and image quantification can be impacted.
In order to establish whether a local apparent increase in radioactivity corresponds to
a specific tracer uptake, the effect must be studied carefully.
From a physics perspective, the lung consists predominantly of three types of
materials; for normal lung, the average fractions have been estimated as follows: 74% air,
16% blood and 10% “lung cells” (i.e. everything in the lung except air and blood) (Chen
et al. 2017). However, pulmonary pathologies can lead to a local or global change of the
lung architecture, including for example a localised decrease of the air content, that can
affect the quantification of PET images. In this paper we will refer to lung “tissue” as
being everything in the lung except the air, similarly as in Lambrou et al. (2011).
Lung cancer is one of the main causes of death in the world and the main cause
of cancer mortality worldwide (Postmus et al. 2017). Tumour staging and follow-up
are essential for a better prognosis, with increased utilisation of PET/CT imaging,
particularly via measurement of 18F-FDG uptake (Nakamura et al. 2015). Most lung
tumours have a density close to that of soft tissue (≈ 1 g · cm−3, Xu et al. (2008)),
whereas the rest of the lung has a far lower density (≈ 0.26 g · cm−3). This means that
there is usually an abrupt change of density at the interface of the tumour with the
rest of the lung. In the case of idiopathic pulmonary fibrosis (IPF) – characterised by
a build-up of scarring tissue within the lungs – the fibrotic regions of the lungs have an
increased density compared to the healthy parts of the lungs. Localised high-density
structures, such as honeycombing, increase in extent as disease progresses (Spagnolo
et al. 2015).
Several radionuclides will be studied in this work: 18F, 68Ga, 82Rb, 15O, 89Zr,
64Cu and 124I. Besides 18F, 68Ga is increasingly used to label biological ligands such as
DOTATATE which targets somatostatin receptors. Another example is prostate-specific
membrane antigen (68Ga-PSMA) which targets tumour neovasculature and has shown
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promising results, mainly for prostate cancer but also more recently in the lung (Chang
et al. 1999, Wang et al. 2015). 68Ga has the disadvantage of having a larger positron
range than 18F. 82Rb or 15O are less commonly used in PET lung imaging, however
these can be used to evaluate perfusion. Other radionuclides of recent interest in PET
are 89Zr, 64Cu and 124I which, because of their relatively long half-life, are potentially
useful for imaging lung cancers using radiolabelled monoclonal antibodies, for which the
circulation half-life is generally on the order of days (Reichert & Valge-Archer 2007).
In the case of a positron-emitting point source, the probability of annihilation can
be expressed as a 3D distribution and the image corresponding to the annihilation
events (“annihilation image”) can be viewed as the convolution by a blurring kernel of
the image corresponding to the positron emission events (“emission image”). In uniform
media, previous work on estimating positron range involved computation of 1D or 2D
annihilation range distributions from the actual distribution (Blanco 2006, Levin &
Hoffman 1970, Derenzo 1979, Cal-González et al. 2010, Jødal et al. 2012, Cal-González
et al. 2013). Although using one of the previous methods is satisfactory in a relatively
uniform medium, it may be inaccurate in highly heterogeneous media or near a boundary
between two regions with very different densities. In fact, a noticeable difference
compared to a homogeneous medium is that the centre of gravity for activity is not
located at the emission source point, i.e. a shift occurs. We illustrate this here with
a boundary between a high-density medium and a low-density medium (tumour and
healthy lung), obtained from a GATE (Jan et al. 2004) Monte Carlo simulation (see later
in this paper for more details), in Figure 1. In non-homogeneous tissue, the positron
range can be modelled using spatially-variant anisotropic kernels. A good model should
take into account the difference of densities in a neighbourhood. Several strategies
already exist (Bai et al. 2003, Szirmay-Kalos et al. 2012, Alessio & MacDonald 2008, Cal-
González et al. 2015), but have not been validated in humans and may not be applicable
to heterogeneous lungs or for all radionuclides. Furthermore it might be impractical
in clinical settings due to rather lengthy processing. Another possibility for non-
homogeneous media is to use Monte Carlo simulations (Lehnert et al. 2011) to obtain the
positron range distribution via simulations of all possible physical interactions given a
radioactivity distribution. The latter are also computationally expensive and unsuitable
for routine use, but represent a gold standard to assess the effect of positron range on
PET images.
This paper is organised as follows. We briefly discuss the effect of positron range
in uniform media, then describe the Monte Carlo methodology of this paper in detail.
Last, we present results of the effect of positron range in the lungs, in the presence of
small high-density structures within the healthy lung, such as tumour, localised fibrosis
or blood vessels.
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Figure 1: Illustration of positron range effect for a radioactive 82Rb emission source
placed in close proximity (6 mm) to an abrupt density change, showing the number
of emission and annihilation events - emission either in the tumour (top) or in the
(healthy) lung (bottom). The annihilation images (image size of 7.2 x 7.2 x 7.2 cm3 with
voxel of size: 3 x 3 x 3 mm3) were scaled to 1% of the total number of emitted positrons
(≈ 918, 000 for both simulations).
2. Theory and Methodology
2.1. Monte Carlo Simulation Settings
In this work, we used GATE (version 8.2), Monte Carlo simulation software dedicated
to medical imaging (Jan et al. 2004), to simulate the effect of positron range in the
lung. GATE is based on the GEANT4 toolkit (version 10.5.1), which simulates the
particle behaviour through physical matter (Agostinelli et al. 2003); the GATE physics
list “empenelope” accounts for most of the physical interactions involved in PET imaging
to obtain an accurate model of the path an emitted positron takes before annihilating
with an electron, including multiple scattering, ionisation, annihilation or production
of bremsstrahlung. The energy distribution function, for a single β+ transition, can be
approximated as (Levin & Hoffman 1970):






(Emax − E)2 dE (1)
where:
- Z is the atomic number of the mother nucleus, prior beta decay.
- E is the kinetic energy of the positron in MeV.
- Emax is the maximum kinetic energy for the radionuclide, in MeV.
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Table 1: Maximum kinetic energy and atomic number of the studied PET








124I (1) 1.535 53
124I (2) 2.138 53
82Rb (1) 2.605 37





)2 − 1 is the momentum of the positron.
- F (Z,E) = 2πη
1−e−2πη is the Fermi function, where:
• η = −Zα
p
× (1 + E
0.511
), for positron decay.
• α ≈ 1/137 the fine-structure constant, used in fundamental physics.
Mathematica (Wolfram Research 2017) was used to obtain histograms correspond-
ing to the energy distribution of the studied radionuclides, using the values of Z and Emax
in Table 1. Whereas the decay schemes of 18F, 15O, 68Ga, 89Zr, 64Cu are simple (only
one β+ transition), 82Rb and 124I have several β+ transitions. For both radionuclides,
the previous formula 1 was applied to the two transitions with the highest probabilities
to create a total energy distribution as a weighted sum of the separate energy spectra.
The resulting energy spectra are shown in Figure 2. The histogrammed spectra were










Figure 2: Positron emission energy spectra for the different radioisotopes of this study
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Simple point source simulations in water were performed to assess the validity of
the settings by calculating the mean and maximal positron ranges (Rmean and Rmax
respectively) from the GATE output, see Table 2. The values were in good agreement
with Lehnert et al. (2011) for both 18F and 15O, as well as with other more sophisticated
positron range models, although slightly lower.
Table 2: Positron ranges estimated and in literature, in water for the studied
radionuclides.
Estimated Literature
Radionuclide Rmean (mm) Rmax (mm) Rmean (mm) Rmax (mm)
18F 0.44 2.31 0.48a,0.57b,0.6c 2.27a,1.85b,2.6c
64Cu 0.51 2.54 0.56d 2.9d
89Zr 0.87 3.76 1.27d 4.2d
15O 2.00 8.01 2.21a,2.34b,2.5c 7.96a,7.70b,9.1c
68Ga 2.39 9.57 2.69b,2.9c 8.86b,10.3c
124I 2.70 10.57 3.4d 11.7d
82Rb 5.03 16.80 5.33b,5.9c 17.6b,18.6c
a: Lehnert et al. (2011), b: Cal-González et al. (2010), c: Jødal et al. (2012), d: Jødal et al. (2014)
In addition to the definition of radioactive sources, “materials” need to be defined
in GATE to create the simulation phantom. These are defined by the physical elements
comprising them, their fractions, as well as their corresponding mass density. The
default GATE material database comprises only one “Lung” material, which corresponds
to the average composition and density of ’normal’ lung. A material corresponding to
a malignant lung tumour was added to the database with an average CT value of
11 (≈ 1.028 g · cm−3, Xu et al. (2008)) (see Appendix A). In the case of the fibrotic
lung, as its composition is spatially variant depending on the degree of fibrosis, the
material database was modified to incorporate a range of fibrotic lung materials, that
correspond to lung tissues between −800 HU (≈ 0.26 g · cm−3, healthy lung) to −200 HU
(≈ 0.615 g · cm−3, severely fibrotic lung), with a step of 50 HU (≈ 0.3 g · cm−3), using
the different lung fractions given in Chen et al. (2017). The details of the fibrotic lung
materials are given in Appendix B.
2.2. Additional Factors Affecting Resolution in PET
Aside from positron range, PET resolution also depends on other factors such as
detection uncertainties, acolinearity or the reconstruction method (Moses 2011). The
typical spatial resolution for a clinical scanner, characterised for a very small object
source in air comparable to a point source (negligible positron range effect), is
approximately 5 mm (Bettinardi et al. 2011, Jakoby et al. 2011, Kolthammer et al. 2015).
In addition, postfiltering is generally used in PET reconstruction. In clinical practice,
a Gaussian postfilter of Full-Width at Half Maximum (FWHM) ≈ 6 mm is typically
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applied, resulting in a global spatial blurring that we can model via a normal distribution
of FWHM equal to
√
52 + 62 ≈ 8 mm. In the following simulations, the raw results will
be either filtered via a Gaussian filter of FWHM 5 mm or 8 mm to be able to study
the effect of positron range on quantification of reconstructed images in more realistic
conditions.
2.3. Simulation Processing
From the output from a GATE Monte Carlo simulation, the locations of all positron
emission events and the locations of all annihilation events were recorded.
The emission events corresponding to annihilations occurring outside of the
phantom were discarded. In our simulations, the “emission image” E and “annihilation
image” A are computed. These two images were either used directly or postfiltered
in order to mimic measures on PET reconstructed images (see Section 2.2), using two
different Gaussian filters FWHM: 5 mm (unfiltered reconstructed images) and 8 mm
(filtered reconstructed images). From these images, the “apparent recovery ratio” α
of a volume-of-interest (VOI) can be computed, measuring the increase or decrease in
activity within the volume due solely to positron range and postfiltering (if any). In a





where AV,i (respectively EV,i) is the mean number of events in the annihilation image
(respectively the emission image) within V , after postfiltering with a Gaussian of FWHM
imm. In addition to the apparent recovery ratio, the “apparent contrast” CV1/V2,i,
defined as the ratio of AV1,i and AV2,i is calculated to compare the uptake of a VOI V1
to that of a VOI V2, after a postfilter of FWHM imm was applied on the images.
The same definitions are extended to ensembles of VOIs {Vk}k∈N and {Wk}k∈N,




k αWk,i, in which · represents the “mean”
operator.
When comparing the effect of positron range between two complementary media
(i.e. there are only two types of material in the simulation and all events are emitted
and annihilated in either of those), we also compute the fraction SR1/R2 of the number
of emission events emitted from one medium R2 but annihilated in the other medium
R1 over the number of emission events emitted from R1 but annihilated in R2. This
measure will be described as the “spillover” ratio of R1 in R2. If the ratio is > 1 (resp.
< 1), this means that the apparent uptake of the entire R1 is overestimated (resp.
underestimated) because of positron range effects.
3. Simulations
Two pulmonary pathologies were considered in this work, for which two different









Figure 3: Coronal view of the density image used in the simulation showing the
simulation volume (all image) and measurement volume (within the box).
presented in this section.
3.1. Simulations of a Spherical Lung Tumour of Variable Radius
Spherical tumours with three different diameters (1 cm, 2 cm and 3 cm) were simulated
in the normal lung. The VOIs corresponding to the tumours are denoted as T1, T2 and
T3 (corresponding to diameters of 1 cm, 2 cm and 3 cm, respectively). The images of
annihilation and emission were computed using voxels of dimension 1 x 1 x 1 mm3.
3.2. Simulations of a Fibrotic Lung
A diagnostic CT image volume from an IPF patient was used to perform a realistic
simulation of a fibrotic lung. The latter was obtained from a GE Discovery 690,
multislice helical CT acquisition at breathhold covering 27.5 cm with a 1.25 mm slice
thickness and a pitch of 0.516, with 120 kVp, 149 mA and 0.6 s revolution time. The
image was segmented into several fibrotic lung materials, according to their Hounsfield
value (Section 2.1). The outside of the lung was considered as liquid water for the
simulation (GATE default database: d = 1 g · cm−3). For computational reasons, the
original CT image was cropped to a volume of 10 x 10 x 10 cm3 for the simulation. In
order to avoid issues with border effects, the emission and annihilation events occurring
near the edges of the input CT image were not considered and the measurements were
made within a volume of 6 x 6 x 6 cm3. A slice through the CT image is presented in
Figure 3.
The images of annihilation and emission were computed using voxels of dimension
0.5 x 0.5 x 0.5 mm3 and were analysed using two VOI sizes - small (3 x 3 x 3 mm3) and
medium-sized (9 x 9 x 9 mm3) – at 20 locations – determined on the density map:
* 10 predominantly normal lung
– small VOIs “N1”: mean density ± standard deviation = 0.263± 0.016 g · cm−3
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– medium-sized VOIs “N2”: mean density ± standard deviation = 0.274 ±
0.045 g · cm−3
* 10 predominantly fibrotic lung
– small VOIs “F1”: mean density ± standard deviation = 0.574± 0.171 g · cm−3
– medium-sized VOIs “F2”: mean density ± standard deviation = 0.431 ±
0.224 g · cm−3
3.3. Radioactivity Distributions
For each simulation presented above, two radioactivity distributions were assessed:
- Scenario 1 : the radioactivity concentration is uniform throughout the whole lung.
- Scenario 2 : the radioactivity concentration is uniform in the “tissue” (introduced
previously in 1 as everything in the lung outside the air) and that there is no
radioactivity in the air. The resulting radioactivity concentration in each voxel is
therefore obtained by multiplying with 1 − Va, where Va is the air fraction in the
lung medium (given in Appendix B).
The minimal numbers of emission/annihilation events retained are the following:
(1) Lung Tumours: ≈ 2·108 for Scenario 1 and ≈ 5·107 for Scenario 2, (2) Fibrotic Lung:
≈ 8 · 107 for Scenario 1 and ≈ 3 · 107 for Scenario 2. In both scenarios, the neighbouring
soft tissue does not have any radioactivity. For conciseness, only images corresponding
to the simulations of 18F, 68Ga and 82Rb will be shown in this publication. Note that
89Zr and 64Cu have similar energy spectra to 18F and 15O and 124I to 68Ga 2, therefore
similar positron ranges.
In the case of the lung tumour simulations, in order to study the effect of the
“background” level (i.e., the relative amount of activity in the healthy lung respectively
to the tumour), intermediary apparent recovery values were found from the results of
Scenario 1, by rescaling the annihilation and emission images corresponding to emission
events occurring in the healthy tissue.
4. Results
4.1. Simulation of Spherical Lung Tumours
4.1.1. Scenario 1: The apparent recovery α measured from the different tumours T1,
T2 and T3 for scenario 1 can be found in Table 3, including measures made before and
after postfiltering.
Before any postfiltering, a halo can be seen on the outside edge of the tumour,
see images corresponding to T2 in Figure 4. After postfiltering, the halo either almost
disappears (18F, 89Zr and 64Cu) or is blurred out to appear as an increased uptake in
the tumour compared to the healthy lung background (82Rb, 124I, 68Ga and 15O). The
effect is amplified for 82Rb where the tumour resembles a hot spot on the image.
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Table 3: Lung Tumour - Scenario 1 - Apparent recovery computed from the emission
and annihilation images for the studied radionuclides in the tumour (diameters: 1 cm,
2 cm and 3 cm). αTk, i is the apparent recovery for a tumour of diameter k cm, after a
postfilter of FWHM imm.
Radionuclide αT1, 0 αT1, 5 αT1, 8 αT2, 0 αT2, 5 αT2, 8 αT3, 0 αT3, 5 αT3, 8
18F 1.116 1.029 1.011 1.060 1.018 1.010 1.040 1.013 1.007
64Cu 1.146 1.041 1.017 1.073 1.024 1.014 1.049 1.017 1.010
89Zr 1.292 1.097 1.042 1.147 1.059 1.036 1.098 1.041 1.027
15O 1.766 1.348 1.179 1.403 1.224 1.157 1.269 1.156 1.115
68Ga 1.918 1.434 1.229 1.490 1.284 1.203 1.329 1.199 1.149
124I 2.072 1.525 1.284 1.497 1.290 1.209 1.379 1.237 1.182
82Rb 2.705 1.915 1.513 2.038 1.717 1.550 1.718 1.520 1.421
Table 4: Lung Tumours - Scenario 1 - Spillover ratios corresponding to the tumour,
computed from the emission and annihilation images for the studied radionuclides in
the tumour (diameters: 1 cm, 2 cm and 3 cm). Tk represents the tumour of diameter
k cm.
Radionuclide ST1/N ST2/N ST3/N
18F 1.987 1.680 1.840
64Cu 2.111 1.801 1.941
89Zr 2.498 2.239 2.351
15O 3.102 2.977 3.046
68Ga 3.198 3.087 3.161
124I 3.344 3.116 3.247
82Rb 3.482 3.442 3.494
The spillover ratios for the tumours T1, T2 and T3 in the background N are given
in Table 4, where N represents the outside of the tumour, comprising normal lung.
All measures show that the shift of radioactivity from the outside of the tumours,
that is low-density lung, to the tumour is greater than the opposite, i.e. the shift from
the tumour to the normal lung.
4.1.2. Scenario 2: The recovery ratios were all close to 1 (with and without
postfiltering), see in Table 5. The images for T2 are shown in Figure 5.
Visually the images for 18F, 68Ga and 82Rb are almost identical. However, the
measured values show that the effect observed in Scenario 2 is dominated by the “spill-
out”, i.e. there are more positrons emitted from the tumours that are annihilated in the
normal lung than the opposite. This can be verified by computing, on the unfiltered
images, the spillover ratios of the tumours. The results are given in Table 6 for all
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Figure 4: Lung Tumour (2 cm) - Scenario 1 - (a) (resp. (e), (i)) emission events, (b)
(resp. (f), (j)) annihilation events, (c) (resp. (g), (k)) 5 mm postfiltered annihilation
events and (d) (resp. (h), (l)) 8 mm postfiltered annihilation events computed for 18F
(top row) (resp. 68Ga (middle row), 82Rb (bottom row)). All images are scaled using
the same colourbar (maximal value of the unfiltered 82Rb annihilation image).
The spillover ratios are indeed all inferior to 1.
4.1.3. Intermediary Scenarios The change of balance between spill-in and spill-out can
be observed in Figure 6 (for 18F, 68Ga and 82Rb and tumours of 1 cm and 2 cm). The
plots show the apparent recovery values for different levels of activity in the healthy lung
(“background”) after a 8-mm postfilering. For this type of small tumours, it appears
that the apparent recovery are ≈ 1 when λT /dT ≈ λN/dN (where λT (resp. λN ) is
the activity concentration in the tumour (resp. the healthy lung) and dT (resp. dN ) is
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Table 5: Lung Tumours - Scenario 2 - Apparent recovery computed from the emission
and annihilation images for the studied radionuclides in the tumour (diameters: 1 cm,
2 cm and 3 cm). αTk, i is the apparent recovery for a tumour of diameter k cm, after a
postfilter of FWHM imm.
Radionuclide αT1, 0 αT1, 5 αT1, 8 αT2, 0 αT2, 5 αT2, 8 αT3, 0 αT3, 5 αT3, 8
18F 1.002 0.998 0.997 1.001 1.000 0.999 1.001 1.000 1.000
64Cu 1.002 0.999 0.998 1.001 1.000 0.999 1.001 1.000 1.000
89Zr 1.006 0.999 0.996 1.003 1.000 0.999 1.001 1.000 1.000
15O 1.004 0.997 0.990 1.005 1.003 1.001 1.003 1.002 1.001
68Ga 1.011 1.003 0.993 1.004 1.002 1.000 1.003 1.002 1.001
124I 1.017 1.009 0.999 1.006 1.004 1.002 1.004 1.003 1.002
82Rb 1.013 1.006 0.995 1.006 1.005 1.010 1.004 1.004 1.003
Table 6: Lung Tumours - Scenario 2 - Spillover ratios corresponding to the tumour,
computed from the emission and annihilation images for the studied radionuclides in
the tumour (diameters: 1 cm, 2 cm and 3 cm). Tk represents the tumour of diameter
k cm.
Radionuclide ST1/N ST2/N ST3/N
18F 0.523 0.441 0.480
64Cu 0.556 0.469 0.504
89Zr 0.660 0.588 0.612
15O 0.800 0.775 0.793
68Ga 0.843 0.805 0.821
124I 0.865 0.827 0.844
82Rb 0.904 0.897 0.911
the mass density of the tumour (resp. the healthy lung)), i.e., which is equivalent to
Scenario 2. Below that threshold (indicated by the vertical dotted line in Figure 6) the
change in spill-in/spill-out fractions leads to a negative bias in the apparent recovery of
the tumour. This is also the case for other radionuclides and tumour of 3 cm.
4.2. Simulation of a Fibrotic Lung
4.2.1. Scenario 1: The emission images and the unfiltered and filtered annihilation
images for the seven studied radionuclides can be found in Figure 7, with the
corresponding measures of apparent recovery and apparent contrast for different
postfiltering in Tables 7 and 8.
This case is similar to Scenario 1 of the tumour simulations: when the radioactivity
is evenly distributed among the different lung types, the fibrotic parts of the lung
(corresponding to the regions with higher density) appear to have higher radioactivity
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Figure 5: Lung Tumour (2 cm) - Scenario 2 - (a) (resp. (e), (i)) emission events, (b)
(resp. (f), (j)) annihilation events, (c) (resp. (g), (k)) 5 mm postfiltered annihilation
events and (d) (resp. (h), (l)) 8 mm postfiltered annihilation events computed for 18F
(top row) (resp. 68Ga (middle row), 82Rb (bottom row)). All images are scaled using
the same colourbar (maximal value of the unfiltered 82Rb annihilation image).
4.2.2. Scenario 2: The emission images and the unfiltered and filtered annihilation
images for the seven studied radionuclides can be found in Figure 8, with the
corresponding measures of apparent recovery values for different amounts of postfiltering
in Table 9. Similarly as Scenario 2 for the tumours, especially 82Rb, the apparent
recovery ratio values do not demonstrate a positive quantitative bias in the high-density
medium (here the fibrosis) due to positron range, but a negative bias; this suggests that
more positrons emitted from the fibrotic lung are annihilated in the normal lung than
the opposite.
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Figure 6: Plots showing the apparent recovery values (a.) αT1, 8 (tumour of diameter
1 cm) and (b.) αT2, 8 (tumour of diameter 2 cm), for different background levels (8-mm
Gaussian postfiltering). The vertical dotted line indicates the threshold value for which
the apparent recovery values are ≈ 1 for all radionuclides.
Table 7: Fibrotic Lung - Scenario 1 - Mean apparent recovery values computed from
the original emission and annihilation images for all studied radionuclides. αV, i is the
apparent recovery for a VOI V (description in 3.2), after a postfilter of FWHM imm.
Measure 18F 64Cu 89Zr 15O 68Ga 124I 82Rb
αN1,0 0.987 0.970 0.976 0.924 0.918 0.896 0.820
αN2,0 0.997 0.995 0.987 0.953 0.942 0.927 0.850
αF1,0 1.073 1.089 1.196 1.513 1.515 1.557 1.619
αF2,0 1.016 1.022 1.049 1.168 1.166 1.182 1.172
αN1,5 0.995 0.992 0.984 0.948 0.937 0.921 0.848
αN2,5 0.997 0.995 0.989 0.959 0.948 0.933 0.858
αF1,5 1.026 1.035 1.075 1.195 1.224 1.247 1.248
αF2,5 1.010 1.014 1.031 1.094 1.109 1.119 1.097
αN1,8 0.997 0.996 0.990 0.961 0.951 0.937 0.863
αN2,8 0.998 0.997 0.992 0.965 0.956 0.942 0.868
αF1,8 1.010 1.014 1.087 1.116 1.101 1.111 1.087
αF2,8 1.006 1.008 1.051 1.051 1.059 1.063 1.028
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Table 8: Fibrotic Lung - Scenario 1 - Mean apparent contrasts computed from the
original emission and annihilation images for all studied radionuclides. C·, i is the
apparent contrast between VOIs (description in 3.2), after a postfilter of FWHM imm.
Measure 18F 64Cu 89Zr 15O 68Ga 124I 82Rb
CF1/N1,0 1.073 1.103 1.195 1.511 1.581 1.645 1.862
CF2/N2,0 1.015 1.021 1.051 1.167 1.199 1.231 1.322
CF1/N1,5 1.028 1.039 1.082 1.232 1.272 1.312 1.419
CF2/N2,5 1.011 1.016 1.036 1.119 1.143 1.169 1.239
CF1/N1,8 1.011 1.016 1.083 1.116 1.139 1.163 1.230
CF2/N2,8 1.006 1.009 1.047 1.076 1.093 1.111 1.163
Table 9: Fibrotic Lung - Scenario 2 - Mean apparent recovery values computed from
the original emission and annihilation images for all studied radionuclides. αV, i is the
apparent recovery for a VOI V (description in 3.2), after a postfilter of FWHM imm.
Measure 18F 64Cu 89Zr 15O 68Ga 124I 82Rb
αN1,0 1.003 1.001 1.006 1.014 1.002 1.009 0.975
αN2,0 1.000 1.000 1.001 1.005 1.002 1.000 0.966
αF1,0 1.011 1.004 1.009 1.006 1.000 0.993 0.956
αF2,0 1.001 0.999 0.999 0.995 0.991 0.987 0.939
αN1,5 1.001 1.001 1.002 1.007 1.002 1.001 0.968
αN2,5 1.000 1.000 1.001 1.003 1.001 0.999 0.964
αF1,5 1.001 1.000 0.999 0.995 0.989 0.984 0.938
αF2,5 1.000 0.999 0.999 0.995 0.991 0.986 0.936
αN1,8 1.000 1.000 1.001 1.003 1.000 0.999 0.963
αN2,8 1.000 1.000 1.001 1.001 1.000 0.998 0.959
αF1,8 1.000 0.999 0.999 0.993 0.988 0.982 0.932
αF2,8 1.000 1.000 0.999 0.994 0.990 0.984 0.932
5. Discussion
In this work, we have simulated in the lung two different scenarios. In the first scenario,
the entire lung (comprising of healthy lung, lung tumour or fibrotic lung) was considered
to have the same radioactivity concentration. In the second scenario, the air in the
lung was assumed to contain no radioactivity, meaning the radioactivity was evenly
distributed over the “tissue” in the lung (defined as “everything but the air”). The
latter scenario corresponds to the situation where the normal lung tissue has the same
radiotracer uptake as the tumour or fibrotic tissue.
The results of the simulations show that, although positron range is usually
perceived as a blurring effect, in heterogeneous media it should rather be considered
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Figure 7: Fibrotic Lung - Scenario 1 - (a) (resp. (e), (i)) emission events, (b) (resp. (f),
(j)) annihilation events, (c) (resp. (g), (k)) 5 mm postfiltered annihilation events and
(d) (resp. (h), (l)) 8 mm postfiltered annihilation events computed for 18F (top row)
(resp. 68Ga (middle row), 82Rb (bottom row)). All images are scaled using the same
colourbar (110% of the maximal value of the unfiltered 82Rb annihilation image).
structures are more likely to “capture” some of the activity from the neighbouring lower
density structures, than the opposite.
In the case of a high-density tumour located within a healthy lung, a part of
the activity of the surrounding low-density area will be transferred to the tumour
(“spill-in”), as well as some activity from the tumour to the healthy lung (“spill-
out”). In the first scenario (even distribution), the tumour will appear hotter on the
PET images, as the spill-out is largely dominated by the spill-in. However, in the
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Figure 8: Fibrotic Lung - Scenario 2 - (a) (resp. (e), (i)) emission events, (b) (resp. (f),
(j)) annihilation events, (c) (resp. (g), (k)) 5 mm postfiltered annihilation events and
(d) (resp. (h), (l)) 8 mm postfiltered annihilation events computed for 18F (top row)
(resp. 68Ga (middle row), 82Rb (bottom row)). All images are scaled using the same
colourbar (maximal value of the unfiltered 82Rb annihilation image).
in, which leads to apparent recovery values ≈ 1. When varying the level of activity
in the surrounding healthy lung (see Figure 6), the changes of spill-in and spill-out
fractions lead to either positive or negative biases in the apparent recovery values. The
radioactivity distribution of Scenario 2 acts as a “threshold”: when the radioactivity
of the healthy lung is lower than the one of Scenario 2, the recovery values will be
negatively impacted, if higher, positively impacted. When there is no activity in the
healthy lung, the observations are consistent with Kemerink et al. (2011), where a similar
experiment was performed using syringes of various sizes containing activity in water
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(water density ≈ lung tumour density). They were placed in cellular polyethylene foam
(density 0.164 g · cm−3) to mimic a healthy lung. As no background activity was used
(therefore observing only spill-out from the syringe), only spill-out was observed, which
led to a negative bias in the tumour recovery values.
The spill-in effect of the positron range is mostly noticeable at the edges of the
tumour, with the “penetration depth” depending on the radionuclide and expected to
be related to the “mean positron range in water”, with Rmean ≈ 5 mm for 82Rb, i.e. half
the radius). That implies that the spill-in effects need to be considered for structures
of about twice the mean positron range – the magnitude depending on the radioactive
concentration in the background. In this study, lung tumours were modelled with a
uniform density and a spherical shape. The composition of a lung tumour is usually
more diverse (e.g. with necrotic regions, see Travis et al. (2015)) and could lead to more
complex positron range effects.
The results from the simulation of a fibrotic lung show the same trend as for the
tumour. In the first scenario (uniform distribution), a large bias in the apparent
radioactivity of the fibrotic lung is observed (up to ≈ +61.9% for unfiltered 82Rb
images), with a highly heterogeneous distribution overall. In the second scenario (air
containing no activity), the apparent recovery ratio is slightly less than 1 for high-energy
radionuclides, meaning that the spill-out is now dominant (minimum found of 0.939 in
a VOI of dimension 9 x 9 x 9 mm3 for 82Rb).
The observations shown here have implications for other situations. For example,
the shift in measured radionuclide concentration to the higher density medium could be
observed in the case of a metal implant or prosthetic in close proximity to a low-density
medium. Such effect could be expected for cardiac imaging near the lung, however the
effect of cardiac motion might prevail. Also, Chronic Obstructive Pulmonary Disease,
one of the main causes of global mortality (Martinez et al. 2011) is mainly characterised
by emphysema and air trapping, which leads to a locally lower density of the lung,
meaning that positron range effects may be more prominent for this pathology. More
generally the spill-in dominance is most relevant for cold-spot imaging, such as the
detection of myocardial defects in PET (Rahmim et al. 2008). However for most
purposes, PET tracers are more likely to have higher uptake in high-density regions
(as expected for 18F-FDG in IPF (Win et al. 2012)). The second scenario is therefore
more realistic and the increase of apparent recovery in the high-density regions due
to spill-in from the background healthy regions should be limited in the case where
spill-out dominates, e.g. in tumour imaging. Our aim in this study was to better
understand the possible effects that may be introduced in lung studies due to positron
range, with particular emphasis on the quantitative bias that may be introduced. Our
simulations therefore were conducted without noise so that the source of bias could
be easily visualised. In practice, when noise is present, the underlying distribution
of annihilation locations may not be visually observed, however, bias in quantitative
measurements would remain. We therefore consider that the noise-free illustrative
examples are useful. The effect of positron range will also be more visible for pre-clinical
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systems, because of better spatial resolution (Yang et al. 2016). Note that, positron
ranges were found to be lower than ranges estimated with alternative models (Cal-
González et al. 2010, Jødal et al. 2012, Jødal et al. 2014), suggesting that the positron
range effect might be underestimated in this work. Nonetheless, the results of the
simulations presented in this paper (without postfiltering) may provide an indication of
the magnitude of this effect, although additional simulations with appropriate object
size as well as phantom acquisitions would be necessary to assess this in detail.
This paper was aimed at providing some insights on the effect of positron range
in heterogeneous media. The use within an iterative reconstruction of anisotropic
kernels (Bai et al. 2003, Alessio & MacDonald 2008, Szirmay-Kalos et al. 2012, Rahmim
et al. 2008, Cal-González et al. 2015) or Monte Carlo simulations (Lehnert et al. 2011)
could be verified for positron range compensation: the effects and bias observed in this
work could potentially be reduced by incorporating one of these strategies, however the
high computational cost might be a limiting factor in clinical settings (especially for
the fibrotic lung where no clear uniform region can be used for correction); this will be
the subject of future work. In the absence of an accurate positron range compensation
method, when measuring the radioactivity concentration of a tumour or localised high-
density regions in the lung, the reported radioactivity concentration values should be
evaluated with caution when using of a tracer labelled with a radionuclide that emits
high-energy positrons.
6. Conclusion
Positron range can be an important source of image degradation in PET imaging, as
the events recorded by the detectors are not directly reflecting the radioactivity, but the
annihilation events that occur after the radioactive decay. The effect is often considered
as a blurring due to spill-out. Whilst this the case in soft tissues and more generally
in a region where the density is homogeneous, in heterogeneous media the actual effect
observed in this paper is more complex, especially in the presence of boundaries between
high and low density materials.
We have shown that in the lung, there is a bias in the annihilation images (in
addition to the apparent blurring) as a result of the interface of the low-density healthy
lung with small structures of high density, such as tumours or fibrosis. This bias is due
to the fact that the probability of positron annihilation is higher in the high-density
features, therefore resulting in positive bias in activity in the high-density regions and
negative bias in the low-density regions. Our simulations indicate that this effect may
be important for imaging radionuclides emitting high-energy positrons such as 68Ga, 124I
or 82Rb when both media have a similar radioactivity concentration. However, for low-
energy positrons or for cases where the high-density medium has a higher radioactivity
than low-density medium, e.g. due to a different fraction of air, the spill-out becomes
more predominant and other types of image degradation (e.g. due to data acquisition and
reconstruction inaccuracies) are expected to have a larger impact on the quantification.
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Appendix A. Lung Tumour Material in GATE
LungTumour : d=1.028 g/cm3 ; n=8
+e l : name=Hydrogen ; f =0.106
+e l : name=Carbon ; f =0.284
+e l : name=Nitrogen ; f =0.026
+e l : name=Oxygen ; f =0.578
+e l : name=Phosphor ; f =0.001
+e l : name=Su l fu r ; f =0.002
+e l : name=Chlor ine ; f =0.002
+e l : name=Potassium ; f =0.001
Appendix B. Fibrotic Lung Materials in GATE
LungTissue : d=0.89 g/cm3 ; n=9
+e l : name=Hydrogen ; f =0.106
+e l : name=Carbon ; f =0.096
+e l : name=Nitrogen ; f =0.019
+e l : name=Oxygen ; f =0.765
+e l : name=Sodium ; f =0.003
+e l : name=Phosphor ; f =0.003
+e l : name=Su l fu r ; f =0.004
+e l : name=Chlor ine ; f =0.003
+e l : name=Potassium ; f =0.001
Lung−800: d=0.26 g/cm3 ; n=3
+mat : name=Air ; f =0.74
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.1
Lung−750: d=0.289 g/cm3 ; n=3
+mat : name=Air ; f =0.7067
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.1333
Lung−700: d=0.319 g/cm3 ; n=3
+mat : name=Air ; f =0.6734
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.1666
Lung−650: d=0.348 g/cm3 ; n=3
+mat : name=Air ; f =0.6401
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.1999
Lung−600: d=0.378 g/cm3 ; n=3
+mat : name=Air ; f =0.6068
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+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.2332
Lung−550: d=0.408 g/cm3 ; n=3
+mat : name=Air ; f =0.5735
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.2665
Lung−500: d=0.437 g/cm3 ; n=3
+mat : name=Air ; f =0.5402
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.2998
Lung−450: d=0.467 g/cm3 ; n=3
+mat : name=Air ; f =0.5069
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.3331
Lung−400: d=0.496 g/cm3 ; n=3
+mat : name=Air ; f =0.4736
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.3664
Lung−350: d=0.526 g/cm3 ; n=3
+mat : name=Air ; f =0.4403
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.3997
Lung−300: d=0.555 g/cm3 ; n=3
+mat : name=Air ; f =0.407
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.433
Lung−250: d=0.585 g/cm3 ; n=3
+mat : name=Air ; f =0.3737
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.4663
Lung−200: d=0.615 g/cm3 ; n=3
+mat : name=Air ; f =0.34
+mat : name=Blood ; f =0.16
+mat : name=LungTissue ; f =0.5
